Adjuvant Radiotherapy after Surgical Excision in Keloids

Medicina (Kaunas). 2021 Jul 19;57(7):730. doi: 10.3390/medicina57070730.

Abstract

Keloids are a benign fibroproliferative disease with a high tendency of recurrence. Keloids cause functional impairment, disfigurement, pruritus, and low quality of life. Many therapeutic options have been used for keloids. However, the high recurrence rates have led to the use of adjuvant therapy after surgical keloid excision. There are different radiotherapy regimens available, and the advantages and disadvantages of each are still unclear. The aim of this review is to explain the appropriate radiotherapy regimen for keloids as well as discuss the recent reports on keloid management with radiotherapy. Adjuvant radiotherapy after surgical excision for keloids yields excellent local control with tolerable side effects. Hypofractionated radiotherapy with a BED of more than 28 Gy (α/β value of 10) after excision is recommended in the light of its biologic background.

Keywords: adjuvant radiotherapy; keloid; surgery.

Publication types

  • Review

MeSH terms

  • Combined Modality Therapy
  • Humans
  • Keloid* / radiotherapy
  • Keloid* / surgery
  • Quality of Life
  • Radiotherapy, Adjuvant
  • Recurrence
  • Treatment Outcome